Clinical Trials | January 17, 2026
GCCL and OPIS forge global clinical trial alliance
GCCL aims to leverage the partnership to expand strategic relationships with global CROs
GCCL aims to leverage the partnership to expand strategic relationships with global CROs
Experts caution that realizing AI’s potential requires careful management and risk mitigation
BioNTech is positioning 2026 as a defining year in its transition toward a multi-product oncology company
The partnership will launch a Phase 1b cohort within Boehringer’s ongoing Beamion-BCGC1 trial
GRIN-NDD is one of the most complex neurodevelopmental disorders with limited treatment options today
Projects selected for advancement will move forward through the Harvard Office of Technology Development’s processes for sponsored research agreements
New 35,000-square-foot facility in Winter Park will expand RLT manufacturing footprint to optimize delivery for patients across southeastern US
InflaRx is streamlining operations and largely discontinuing non-essential activities outside izicopan’s development
Ventyx's clinical pipeline includes multiple small molecules with potential for oral therapies addressing chronic inflammation
Blood tests measuring biomarkers such as p-tau217 are emerging as accurate, accessible alternatives
Subscribe To Our Newsletter & Stay Updated
